Abstract:Oxidative stress-induced cytoskeletal dysfunction of neurons has been implicated as a crucial cause of cell apoptosis or death in the central nervous system (CNS) diseases, such as neurodegenerative and psychiatric diseases. The application of neuroprotectants rescuing the neurons from cytoskeletal damage and apoptosis can be a potential treatment for these CNS diseases. Ginsenoside Rg1 (Rg1), one of the major active components of ginseng, has been reported possessing notable neuroprotective activities. However, there is rare report about its effect on cytoskeleton and its undergoing mechanism. The current study is to reveal the regulatory effects of Rg1 on cytoskeletal and morphological lesion in oxidative stress-induced neuronal apoptosis. The results demonstrated that pre-treatment with Rg1 (0.1-10 μM) attenuated hydrogen peroxide (H2O2)-induced neuronal apoptosis and oxidative stress through reducing the intracellular reactive oxygen species (ROS) production and methane dicarboxylic aldehyde (MDA) level. The Rg1 treatment also abolished H2O2-induced morphological changes, including cell rounding, membrane blebbing, neurite retraction and nuclei condensation, which were generated by myosin IIA-actin interaction. These effects were mediated via the down-regulation of caspase-3, ROCK1 (Rho-associated kinase1) activation and myosin light chain (MLC, Ser-19) phosphorylation. Furthermore, inhibiting myosin II activity with blebbistatin partly blocked the neuroprotective effects of Rg1. The computer-aided homology modelling revealed that Rg1 preferentially positioned in the actin binding cleft of myosin IIA and might block the binding of myosin IIA to actin filaments. Accordingly, the neuroprotective mechanism of Rg1 is related to the activity that inhibits myosin IIA-actin interaction and the caspase-3/ROCK1/MLC signaling pathway. These findings put some insights into the unique neuroprotective properties of Rg1 associated with the regulation of myosin IIA-actin cytoskeletal structure under oxidative stress and provide experimental evidence for Rg1 in CNS diseases.

Ginsenoside Rg1 Inhibits Autophagy in H9c2 Cardiomyocytes Exposed to Hypoxia/reoxygenation

Ginsenoside Rg1 Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury Via Activation of Nrf2/HO-1 Signaling and Inhibition of JNK

Protective effect of ginsenoside Rg1 on hypoxia/reoxygenation injury and its mechanism

Ginsenoside Rg1 Protects Rat Cardiomyocyte from Hypoxia/reoxygenation Oxidative Injury Via Antioxidant and Intracellular Calcium Homeostasis.

Ginsenoside Rg 1 Protects Starving H 9 C 2 Cells by Dissociation of Bcl-2-Beclin 1 Complex

Ginsenoside Rg1 Ameliorates Rat Myocardial Ischemia-Reperfusion Injury by Modulating Energy Metabolism Pathways

Ginsenoside Rg1 Prevents Doxorubicin-Induced Cardiotoxicity Through The Inhibition Of Autophagy And Endoplasmic Reticulum Stress In Mice

Ginsenoside Rg5 Increases Cardiomyocyte Resistance to Ischemic Injury Through Regulation of Mitochondrial Hexokinase-Ii and Dynamin-Related Protein 1.

Ginsenoside Rg1 Protects H9c2 Cells Against Nutritional Stress-Induced Injury Via Aldolase/ampk/pink1 Signalling

Ginsenoside Rb1 prevents hypoxia-reoxygenation-induced apoptosis in H9c2 cardiomyocytes via an estrogen receptor-dependent crosstalk among the Akt, JNK, and ERK 1/2 pathways using a label-free quantitative proteomics analysis

Ginsenoside Rg1 Inhibits Apoptosis by Increasing Autophagy Via the AMPK/mTOR Signaling in Serum Deprivation Macrophages.

Ginsenoside Rg1 mitigates cerebral ischaemia/reperfusion injury in mice by inhibiting autophagy through activation of mTOR signalling

Ginsenoside Rb1 inhibits autophagy through regulation of Rho/ROCK and PI3K/mTOR pathways in a pressure-overload heart failure rat model

Ginsenoside Rg1 Inhibits Myocardial Ischaemia and Reperfusion Injury Via HIF-1 Α-Erk Signalling Pathways in a Diabetic Rat Model.

Ginsenoside Rg1 Protects Against Oxidative Stress-induced Neuronal Apoptosis Through Myosin IIA-actin Related Cytoskeletal Reorganization

Ginsenoside Rg5 Attenuates Hypoxia-Induced Cardiomyocyte Apoptosis Via Regulating the Akt Pathway.

Exogenous HGF Prevents Cardiomyocytes from Apoptosis after Hypoxia Via Up-Regulating Cell Autophagy.

Ginsenoside Rg1 attenuates mechanical stress-induced cardiac injury via calcium sensing receptor-related pathway

Ginsenoside Rb2 improves heart failure by down-regulating miR-216a-5p to promote autophagy and inhibit apoptosis and oxidative stress

Ginsenoside Rg3 Improves Cardiac Function after Myocardial Ischemia/Reperfusion Via Attenuating Apoptosis and Inflammation

Ginsenoside Re Enhances the Survival of H9c2 Cardiac Muscle Cells Through Regulation of Autophagy.